Edge Therapeutics announced today the election of Robert Spiegel, M.D., FACP, to the Company’s Board of Directors.
Dr. Spiegel spent over 25 years at Schering-Plough where he was deeply involved in clinical development culminating with his position as Chief Medical Officer. Dr. Spiegel retired in 2009 as Chief Medical Officer and Senior Vice President of the Schering-Plough Research Institute, the pharmaceutical research arm of the Schering-Plough Corporation.
Help employers find you! Check out all the jobs and post your resume.
